These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13544994)

  • 1. Effect of a catechol amine blocking agent (dibenzyline) on organ content and urine excretion of noradrenaline and adrenaline.
    SCHAPIRO S
    Acta Physiol Scand; 1958 Jun; 42(3-4):371-5. PubMed ID: 13544994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dissociation by phentolamine of the effects of chemical mediators (adrenalin & noradrenalin) and of the actions induced by sympathetic stimulation].
    SCHMITT H
    Arch Int Pharmacodyn Ther; 1957 Feb; 109(3-4):271-9. PubMed ID: 13425720
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of an adrenolytic drug on the erythrocyte and leukocyte response to epinephrine and norepinephrine in normal dogs.
    HAMILTON LH; HORVATH SM
    Am J Physiol; 1952 Mar; 168(3):704-11. PubMed ID: 14914883
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased urinary excretion of adrenaline and noradrenaline after phenoxybenzamine.
    BENFEY BG; LEDOUX G; MELVILLE KI
    Br J Pharmacol Chemother; 1959 Mar; 14(1):142-8. PubMed ID: 13651592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adrenaline and noradrenaline after phenoxybenzamine administration, and during haemorrhagic hypotension, in normal and adrenalectomized dogs.
    MILLAR RA; KEENER EB; BENFEY BG
    Br J Pharmacol Chemother; 1959 Mar; 14(1):9-13. PubMed ID: 13651572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adverse effect of ascorbic acid on the stability of adrenaline and noradrenaline solutions.
    OESTERLING MJ
    Biochim Biophys Acta; 1957 Apr; 24(1):178-87. PubMed ID: 13426217
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of isolated strips of cat spleen for the assay of alpha-adrenergic blocking compounds.
    BICKERTON RK; ROCKHOLD WT; MICALIZZI ER
    J Pharm Sci; 1962 Sep; 51():837-40. PubMed ID: 13868979
    [No Abstract]   [Full Text] [Related]  

  • 8. Blockade of responses to epinephrine and norepinephrine by dibenamine congeners.
    NICKERSON M; HENRY JW; NOMAGUCHI GM
    J Pharmacol Exp Ther; 1953 Mar; 107(3):300-9. PubMed ID: 13035668
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of histamine death in pertussis-inoculated mice by dibenzyline, an adrenergic blocking agent.
    KIND LS
    J Allergy; 1954 Jan; 25(1):33-5. PubMed ID: 13117609
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the potency of dibenzyline, ilidar, phentolamine (regitine) and tolazoline (priscoline) in blocking the vasoconstrictor responses in canine muscle to lumbar sympathetic stimulation and to intra-arterial injections of L-epinephrine and of L-norepinephrine.
    GREEN HD; DENISON AB; WILLIAMS WO; GARVEY AH; TABOR CG
    J Pharmacol Exp Ther; 1954 Dec; 112(4):462-72. PubMed ID: 13222239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of heart reaction to adrenaline and noradrenaline; beta-receptors and their significance].
    NAESS K
    Nord Med; 1962 Feb; 67():188-9. PubMed ID: 14477830
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of dibenamine and piperidono-methyl-benzodioxane (933F) upon the effect of 1-adrenaline and l-noradrenaline on the isolated rat heart.
    SERIN F
    Acta Physiol Scand; 1952; 26(4):299-311. PubMed ID: 13007486
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of the structure-activity relationship in the adrenergic blocking activity of the beta-haloalkylamines.
    Hansch C; Lien EJ
    Biochem Pharmacol; 1968 May; 17(5):709-20. PubMed ID: 5649889
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the blockade produced by dibenzyline, ilidar, tolazoline and phentolamine of the vasomotor responses in skin induced by sympathetic nerve stimulation with the blockade of its responses to L-epinephrine and L-norepinephrine.
    GREEN HD; MACLEOD JA; ANDERSON DA; DENISON AB
    J Pharmacol Exp Ther; 1954 Oct; 112(2):218-30. PubMed ID: 13212632
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the chemical substances that inhibit the formation and liberation of acetylcholine and noradrenaline of the autonomous nervous system].
    Lorenzo Fernandez P
    An R Acad Nac Med (Madr); 1969; 86(1):55-160 contd. PubMed ID: 5819703
    [No Abstract]   [Full Text] [Related]  

  • 16. An inhibitory action of adrenaline abolished by adrenergic blocking drugs.
    MCDOUGAL MD
    J Physiol; 1953 Jun; 120(4):64P-5P. PubMed ID: 13070266
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of inhibition of amine oxidase on the excretion of administered adrenaline and noradrenaline in cats.
    CORNE SJ
    J Physiol; 1956 Jul; 133(1):13-4P. PubMed ID: 13346652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Similitude of the tensor effects of medium doses of N-ethyl-noradrenaline in normal dog and of strong doses of adrenaline in dog subjected to the action of a pure major sympatholytic].
    RAYMOND-HAMET
    C R Hebd Seances Acad Sci; 1953 May; 236(21):2120-2. PubMed ID: 13067312
    [No Abstract]   [Full Text] [Related]  

  • 19. A re-evaluation of acetylcholine, adrenaline, nor-adrenaline and histamine as possible mediators of the pituitary adreno-corticotrophic activation by stress.
    GUILLEMIN R
    Endocrinology; 1955 Mar; 56(3):248-55. PubMed ID: 14353035
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of the prevention of nicotine convulsions by hexamethonium and by adrenaline blocking agents.
    LAURENCE DR; STACEY RS
    Br J Pharmacol Chemother; 1953 Mar; 8(1):62-5. PubMed ID: 13066696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.